HEADER HYDROLASE/HYDROLASE INHIBITOR 21-FEB-16 5IAE TITLE CASPASE 3 V266F CAVEAT 5IAE CASPASE SHOULD BE CONNECTED TO THE CHLOROMETHYL KETONE CAVEAT 2 5IAE RESIDUAL TERMINUS OF THE INHIBITOR THROUGH HEMITHIOACETAL CAVEAT 3 5IAE BOND, BUT THE MODEL DOES NOT REFLECT THE IDEAL CAVEAT 4 5IAE HEMITHIOACETAL GEOMETRY. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: CASP-3,APOPAIN,CYSTEINE PROTEASE CPP32,CPP-32,PROTEIN YAMA, COMPND 5 SREBP CLEAVAGE ACTIVITY 1,SCA-1; COMPND 6 EC: 3.4.22.56; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ACE-ASP-GLU-VAL-ASK; COMPND 11 CHAIN: D, E; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP3, CPP32; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: UNIDENTIFIED; SOURCE 11 ORGANISM_TAXID: 32644 KEYWDS ALLOSTERY, SATURATION MUTAGENESIS, CONFORMATIONAL SELECTION, NATIVE KEYWDS 2 ENSEMBLE, PROTEIN SOLVATION, PROTEIN STRUCTURE, PROTEIN DYNAMICS, KEYWDS 3 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.J.MACIAG,S.H.MACKENZIE,M.B.TUCKER,J.L.SCHIPPER,P.D.SWARTZ,A.C.CLARK REVDAT 1 26-OCT-16 5IAE 0 JRNL AUTH J.J.MACIAG,S.H.MACKENZIE,M.B.TUCKER,J.L.SCHIPPER,P.SWARTZ, JRNL AUTH 2 A.C.CLARK JRNL TITL TUNABLE ALLOSTERIC LIBRARY OF CASPASE-3 IDENTIFIES COUPLING JRNL TITL 2 BETWEEN CONSERVED WATER MOLECULES AND CONFORMATIONAL JRNL TITL 3 SELECTION. JRNL REF PROC.NATL.ACAD.SCI.USA V. 113 E6080 2016 JRNL REFN ESSN 1091-6490 JRNL PMID 27681633 JRNL DOI 10.1073/PNAS.1603549113 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 80456 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.155 REMARK 3 R VALUE (WORKING SET) : 0.155 REMARK 3 FREE R VALUE : 0.182 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.510 REMARK 3 FREE R VALUE TEST SET COUNT : 2017 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 23.9780 - 3.7205 1.00 5779 147 0.1399 0.1479 REMARK 3 2 3.7205 - 2.9548 1.00 5642 149 0.1381 0.1626 REMARK 3 3 2.9548 - 2.5818 1.00 5637 144 0.1638 0.2084 REMARK 3 4 2.5818 - 2.3460 1.00 5631 147 0.1543 0.1788 REMARK 3 5 2.3460 - 2.1779 1.00 5666 144 0.1467 0.1936 REMARK 3 6 2.1779 - 2.0496 1.00 5638 144 0.1499 0.1914 REMARK 3 7 2.0496 - 1.9470 1.00 5593 144 0.1463 0.1710 REMARK 3 8 1.9470 - 1.8623 1.00 5590 142 0.1600 0.1973 REMARK 3 9 1.8623 - 1.7906 1.00 5619 145 0.1625 0.1895 REMARK 3 10 1.7906 - 1.7289 1.00 5596 145 0.1769 0.1827 REMARK 3 11 1.7289 - 1.6748 1.00 5653 145 0.1797 0.2323 REMARK 3 12 1.6748 - 1.6269 1.00 5554 144 0.1830 0.2085 REMARK 3 13 1.6269 - 1.5841 1.00 5624 143 0.1913 0.2037 REMARK 3 14 1.5841 - 1.5455 0.93 5217 134 0.2078 0.2496 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.120 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4397 REMARK 3 ANGLE : 0.898 5958 REMARK 3 CHIRALITY : 0.059 632 REMARK 3 PLANARITY : 0.005 782 REMARK 3 DIHEDRAL : 15.565 2669 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: AUTHORS STATE THAT THERE IS A REMARK 3 FUNDAMENTAL INCOMPATIBILITY IN THE NAMING OF THE INHIBITOR REMARK 3 STRUCTURE AND THE REFINEMENT PROGRAM CANNOT BE MADE TO ESTABLISH REMARK 3 A BOND THAT EXISTS BETWEEN THE INHIBITOR AND THE PROTEIN AT THE REMARK 3 ACTIVE SITE CYSTEINE. REMARK 4 REMARK 4 5IAE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-SEP-16. REMARK 100 THE DEPOSITION ID IS D_1000218533. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 80456 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.545 REMARK 200 RESOLUTION RANGE LOW (A) : 23.975 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 1.3400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CASPASE-3 VARIANTS WERE CRYSTALLIZED REMARK 280 IN THE PRESENCE OF AC-DEVD-CMK. PROTEINS WERE DIALYZED IN A REMARK 280 BUFFER OF 10 MM TRIS-HCL, PH 8.5, 1 MM DTT. THE PROTEIN WAS REMARK 280 CONCENTRATED TO 10 MG/ML USING AMICON ULTRAFREE CENTRIFUGAL REMARK 280 FILTER DEVICES, AND INHIBITOR, AC-DEVD-CMK RECONSTITUTED IN DMSO, REMARK 280 WAS THEN ADDED AT 5:1 WT:WT, INHIBITOR TO PEPTIDE. THE PROTEIN REMARK 280 WAS DILUTED TO A CONCENTRATION OF 8 MG/ML BY ADDING 10 MM TRIS- REMARK 280 HCL, PH 8.5, CONCENTRATED DTT AND CONCENTRATED NAN3 SO THAT THE REMARK 280 FINAL BUFFER WAS 10 MM TRIS-HCL, PH 8.5, 10 MM DTT, 3 MM NAN3. 2 REMARK 280 UL OF CONCENTRATED PROTEIN WAS MIXED 1:1 WITH WELL BUFFER THAT REMARK 280 CONTAINED 100 MM SODIUM CITRATE, PH 5, 3 MM NAN3, 10 MM DTT AND REMARK 280 17% PEG 6000 W/V. SOLUTIONS WERE INCUBATED AT 18 DEG C USING THE REMARK 280 HANGING DROP METHOD. CRYSTALS GREW WITHIN THREE DAYS FOR WILD- REMARK 280 TYPE CASPASE-3 AND WITHIN TWO WEEKS FOR THE MUTANTS., VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 64.11150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.38250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 64.11150 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.38250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE AC-ASP-GLU-VAL-ASP-CMK IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: AC-ASP-GLU-VAL-ASP-CMK REMARK 400 CHAIN: D, E REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 ASN A 3 REMARK 465 THR A 4 REMARK 465 GLU A 5 REMARK 465 ASN A 6 REMARK 465 SER A 7 REMARK 465 VAL A 8 REMARK 465 ASP A 9 REMARK 465 SER A 10 REMARK 465 LYS A 11 REMARK 465 SER A 12 REMARK 465 ILE A 13 REMARK 465 LYS A 14 REMARK 465 ASN A 15 REMARK 465 LEU A 16 REMARK 465 GLU A 17 REMARK 465 PRO A 18 REMARK 465 LYS A 19 REMARK 465 ILE A 20 REMARK 465 ILE A 21 REMARK 465 HIS A 22 REMARK 465 GLY A 23 REMARK 465 SER A 24 REMARK 465 GLU A 25 REMARK 465 SER A 26 REMARK 465 MET A 27 REMARK 465 ASP A 28 REMARK 465 ASP A 175 REMARK 465 SER A 176 REMARK 465 GLY A 177 REMARK 465 VAL A 178 REMARK 465 ASP A 179 REMARK 465 ASP A 180 REMARK 465 ASP A 181 REMARK 465 MET A 182 REMARK 465 ALA A 183 REMARK 465 CYS A 184 REMARK 465 MET C 1 REMARK 465 GLU C 2 REMARK 465 ASN C 3 REMARK 465 THR C 4 REMARK 465 GLU C 5 REMARK 465 ASN C 6 REMARK 465 SER C 7 REMARK 465 VAL C 8 REMARK 465 ASP C 9 REMARK 465 SER C 10 REMARK 465 LYS C 11 REMARK 465 SER C 12 REMARK 465 ILE C 13 REMARK 465 LYS C 14 REMARK 465 ASN C 15 REMARK 465 LEU C 16 REMARK 465 GLU C 17 REMARK 465 PRO C 18 REMARK 465 LYS C 19 REMARK 465 ILE C 20 REMARK 465 ILE C 21 REMARK 465 HIS C 22 REMARK 465 GLY C 23 REMARK 465 SER C 24 REMARK 465 GLU C 25 REMARK 465 SER C 26 REMARK 465 MET C 27 REMARK 465 ASP C 28 REMARK 465 ASP C 175 REMARK 465 SER C 176 REMARK 465 GLY C 177 REMARK 465 VAL C 178 REMARK 465 ASP C 179 REMARK 465 ASP C 180 REMARK 465 ASP C 181 REMARK 465 MET C 182 REMARK 465 ALA C 183 REMARK 465 CYS C 184 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 279 CG ND1 CD2 CE1 NE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 MET C 233 N CA C O CB CG SD REMARK 480 MET C 233 CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 417 O HOH A 509 1.99 REMARK 500 O HOH C 421 O HOH C 526 2.01 REMARK 500 O HOH C 401 O HOH C 413 2.07 REMARK 500 OH TYR C 195 O HOH C 401 2.07 REMARK 500 O HOH A 597 O HOH A 621 2.09 REMARK 500 OE2 GLU C 272 O HOH C 402 2.09 REMARK 500 O HOH C 612 O HOH C 648 2.10 REMARK 500 O HOH C 625 O HOH D 107 2.14 REMARK 500 O HOH C 563 O HOH C 632 2.19 REMARK 500 OE2 GLU C 98 O HOH C 403 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 657 O HOH C 659 27510 2.09 REMARK 500 O HOH A 557 O HOH C 470 27510 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 64 68.17 -101.99 REMARK 500 ARG A 64 68.17 -103.24 REMARK 500 LYS A 229 -37.18 -136.19 REMARK 500 ARG C 64 68.05 -102.63 REMARK 500 ARG C 144 150.91 -49.81 REMARK 500 LYS C 229 -35.97 -134.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT C 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE D 1 and ASP D 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ASP D 5 and 0QE D 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE E 1 and ASP E 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ASP E 5 and 0QE E 6 DBREF 5IAE A 1 277 UNP P42574 CASP3_HUMAN 1 277 DBREF 5IAE C 1 277 UNP P42574 CASP3_HUMAN 1 277 DBREF 5IAE D 1 6 PDB 5IAE 5IAE 1 6 DBREF 5IAE E 1 6 PDB 5IAE 5IAE 1 6 SEQADV 5IAE PHE A 266 UNP P42574 VAL 266 ENGINEERED MUTATION SEQADV 5IAE LEU A 278 UNP P42574 EXPRESSION TAG SEQADV 5IAE HIS A 279 UNP P42574 EXPRESSION TAG SEQADV 5IAE PHE C 266 UNP P42574 VAL 266 ENGINEERED MUTATION SEQADV 5IAE LEU C 278 UNP P42574 EXPRESSION TAG SEQADV 5IAE HIS C 279 UNP P42574 EXPRESSION TAG SEQRES 1 A 279 MET GLU ASN THR GLU ASN SER VAL ASP SER LYS SER ILE SEQRES 2 A 279 LYS ASN LEU GLU PRO LYS ILE ILE HIS GLY SER GLU SER SEQRES 3 A 279 MET ASP SER GLY ILE SER LEU ASP ASN SER TYR LYS MET SEQRES 4 A 279 ASP TYR PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN SEQRES 5 A 279 LYS ASN PHE HIS LYS SER THR GLY MET THR SER ARG SER SEQRES 6 A 279 GLY THR ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE SEQRES 7 A 279 ARG ASN LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU SEQRES 8 A 279 THR ARG GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER SEQRES 9 A 279 LYS GLU ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL SEQRES 10 A 279 LEU LEU SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR SEQRES 11 A 279 ASN GLY PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE SEQRES 12 A 279 ARG GLY ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS SEQRES 13 A 279 LEU PHE ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP SEQRES 14 A 279 CYS GLY ILE GLU THR ASP SER GLY VAL ASP ASP ASP MET SEQRES 15 A 279 ALA CYS HIS LYS ILE PRO VAL GLU ALA ASP PHE LEU TYR SEQRES 16 A 279 ALA TYR SER THR ALA PRO GLY TYR TYR SER TRP ARG ASN SEQRES 17 A 279 SER LYS ASP GLY SER TRP PHE ILE GLN SER LEU CYS ALA SEQRES 18 A 279 MET LEU LYS GLN TYR ALA ASP LYS LEU GLU PHE MET HIS SEQRES 19 A 279 ILE LEU THR ARG VAL ASN ARG LYS VAL ALA THR GLU PHE SEQRES 20 A 279 GLU SER PHE SER PHE ASP ALA THR PHE HIS ALA LYS LYS SEQRES 21 A 279 GLN ILE PRO CYS ILE PHE SER MET LEU THR LYS GLU LEU SEQRES 22 A 279 TYR PHE TYR HIS LEU HIS SEQRES 1 C 279 MET GLU ASN THR GLU ASN SER VAL ASP SER LYS SER ILE SEQRES 2 C 279 LYS ASN LEU GLU PRO LYS ILE ILE HIS GLY SER GLU SER SEQRES 3 C 279 MET ASP SER GLY ILE SER LEU ASP ASN SER TYR LYS MET SEQRES 4 C 279 ASP TYR PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN SEQRES 5 C 279 LYS ASN PHE HIS LYS SER THR GLY MET THR SER ARG SER SEQRES 6 C 279 GLY THR ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE SEQRES 7 C 279 ARG ASN LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU SEQRES 8 C 279 THR ARG GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER SEQRES 9 C 279 LYS GLU ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL SEQRES 10 C 279 LEU LEU SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR SEQRES 11 C 279 ASN GLY PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE SEQRES 12 C 279 ARG GLY ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS SEQRES 13 C 279 LEU PHE ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP SEQRES 14 C 279 CYS GLY ILE GLU THR ASP SER GLY VAL ASP ASP ASP MET SEQRES 15 C 279 ALA CYS HIS LYS ILE PRO VAL GLU ALA ASP PHE LEU TYR SEQRES 16 C 279 ALA TYR SER THR ALA PRO GLY TYR TYR SER TRP ARG ASN SEQRES 17 C 279 SER LYS ASP GLY SER TRP PHE ILE GLN SER LEU CYS ALA SEQRES 18 C 279 MET LEU LYS GLN TYR ALA ASP LYS LEU GLU PHE MET HIS SEQRES 19 C 279 ILE LEU THR ARG VAL ASN ARG LYS VAL ALA THR GLU PHE SEQRES 20 C 279 GLU SER PHE SER PHE ASP ALA THR PHE HIS ALA LYS LYS SEQRES 21 C 279 GLN ILE PRO CYS ILE PHE SER MET LEU THR LYS GLU LEU SEQRES 22 C 279 TYR PHE TYR HIS LEU HIS SEQRES 1 D 6 ACE ASP GLU VAL ASP 0QE SEQRES 1 E 6 ACE ASP GLU VAL ASP 0QE HET ACE D 1 3 HET 0QE D 6 1 HET ACE E 1 3 HET 0QE E 6 1 HET CL A 301 1 HET CL C 301 1 HET ACT C 302 4 HETNAM ACE ACETYL GROUP HETNAM 0QE CHLOROMETHANE HETNAM CL CHLORIDE ION HETNAM ACT ACETATE ION HETSYN 0QE CHLORO METHYL GROUP FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 0QE 2(C H3 CL) FORMUL 5 CL 2(CL 1-) FORMUL 7 ACT C2 H3 O2 1- FORMUL 8 HOH *590(H2 O) HELIX 1 AA1 HIS A 56 GLY A 60 5 5 HELIX 2 AA2 GLY A 66 LEU A 81 1 16 HELIX 3 AA3 THR A 92 LYS A 105 1 14 HELIX 4 AA4 LEU A 136 PHE A 142 1 7 HELIX 5 AA5 CYS A 148 THR A 152 5 5 HELIX 6 AA6 TRP A 214 ALA A 227 1 14 HELIX 7 AA7 GLU A 231 PHE A 247 1 17 HELIX 8 AA8 ASP A 253 HIS A 257 5 5 HELIX 9 AA9 HIS C 56 GLY C 60 5 5 HELIX 10 AB1 GLY C 66 LEU C 81 1 16 HELIX 11 AB2 THR C 92 LYS C 105 1 14 HELIX 12 AB3 LEU C 136 PHE C 142 1 7 HELIX 13 AB4 CYS C 148 THR C 152 5 5 HELIX 14 AB5 TRP C 214 ALA C 227 1 14 HELIX 15 AB6 GLU C 231 PHE C 247 1 17 HELIX 16 AB7 ASP C 253 HIS C 257 5 5 SHEET 1 AA112 GLU A 84 ASN A 89 0 SHEET 2 AA112 GLU A 43 ASN A 51 1 N ASN A 51 O LYS A 88 SHEET 3 AA112 ARG A 111 LEU A 119 1 O VAL A 117 N ILE A 48 SHEET 4 AA112 LYS A 156 GLN A 161 1 O LEU A 157 N PHE A 114 SHEET 5 AA112 PHE A 193 TYR A 197 1 O LEU A 194 N PHE A 158 SHEET 6 AA112 CYS A 264 SER A 267 -1 O PHE A 266 N TYR A 195 SHEET 7 AA112 CYS C 264 SER C 267 -1 O ILE C 265 N SER A 267 SHEET 8 AA112 PHE C 193 TYR C 197 -1 N TYR C 195 O PHE C 266 SHEET 9 AA112 LYS C 156 GLN C 161 1 N PHE C 158 O LEU C 194 SHEET 10 AA112 ARG C 111 LEU C 119 1 N PHE C 114 O LEU C 157 SHEET 11 AA112 GLU C 43 ASN C 51 1 N ILE C 48 O VAL C 117 SHEET 12 AA112 GLU C 84 ASN C 89 1 O LYS C 88 N ASN C 51 SHEET 1 AA2 3 GLY A 122 GLU A 123 0 SHEET 2 AA2 3 ILE A 126 GLY A 129 -1 O ILE A 126 N GLU A 123 SHEET 3 AA2 3 GLY A 132 ASP A 135 -1 O GLY A 132 N GLY A 129 SHEET 1 AA3 2 ILE A 172 GLU A 173 0 SHEET 2 AA3 2 LYS C 186 ILE C 187 -1 O ILE C 187 N ILE A 172 SHEET 1 AA4 2 LYS A 186 ILE A 187 0 SHEET 2 AA4 2 ILE C 172 GLU C 173 -1 O ILE C 172 N ILE A 187 SHEET 1 AA5 3 GLY A 212 SER A 213 0 SHEET 2 AA5 3 TRP A 206 ASN A 208 -1 N ASN A 208 O GLY A 212 SHEET 3 AA5 3 GLU E 3 VAL E 4 -1 O GLU E 3 N ARG A 207 SHEET 1 AA6 3 GLY C 122 GLU C 123 0 SHEET 2 AA6 3 ILE C 126 GLY C 129 -1 O ILE C 126 N GLU C 123 SHEET 3 AA6 3 GLY C 132 ASP C 135 -1 O GLY C 132 N GLY C 129 SHEET 1 AA7 3 GLY C 212 SER C 213 0 SHEET 2 AA7 3 TRP C 206 ASN C 208 -1 N ASN C 208 O GLY C 212 SHEET 3 AA7 3 GLU D 3 VAL D 4 -1 O GLU D 3 N ARG C 207 LINK C ACE D 1 N ASP D 2 1555 1555 1.33 LINK C ASP D 5 C1 0QE D 6 1555 1555 1.53 LINK C ACE E 1 N ASP E 2 1555 1555 1.32 LINK C ASP E 5 C1 0QE E 6 1555 1555 1.53 SITE 1 AC1 4 LYS A 53 GLY A 66 THR A 67 ASP A 68 SITE 1 AC2 4 LYS C 53 GLY C 66 THR C 67 ASP C 68 SITE 1 AC3 3 LYS C 88 ASN C 89 HOH C 487 SITE 1 AC4 14 TRP C 206 ARG C 207 ASN C 208 SER C 209 SITE 2 AC4 14 TRP C 214 SER C 249 PHE C 250 HOH C 485 SITE 3 AC4 14 GLU D 3 HOH D 103 HOH D 104 HOH D 105 SITE 4 AC4 14 HOH D 108 HOH D 110 SITE 1 AC5 10 ARG C 64 HIS C 121 GLY C 122 GLN C 161 SITE 2 AC5 10 CYS C 163 SER C 205 ARG C 207 VAL D 4 SITE 3 AC5 10 HOH D 107 HOH D 113 SITE 1 AC6 13 ARG A 207 ASN A 208 SER A 209 TRP A 214 SITE 2 AC6 13 SER A 249 PHE A 250 HOH A 498 GLU E 3 SITE 3 AC6 13 HOH E 102 HOH E 103 HOH E 105 HOH E 106 SITE 4 AC6 13 HOH E 109 SITE 1 AC7 9 ARG A 64 HIS A 121 GLY A 122 GLN A 161 SITE 2 AC7 9 CYS A 163 SER A 205 ARG A 207 VAL E 4 SITE 3 AC7 9 HOH E 108 CRYST1 128.223 68.765 84.706 90.00 131.34 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007799 0.000000 0.006860 0.00000 SCALE2 0.000000 0.014542 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015723 0.00000